Amanote Research
Register
Sign In
Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)
Science-Business eXchange
doi 10.1038/scibx.2013.211
Full Text
Open PDF
Abstract
Available in
full text
Date
March 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
THU0694 Effects of ANTI-TNF Therapy on Solubile Urokinase Plasminogen Activator Receptor (SUPAR) Levels in Arthritis
Monitoring of Chemotherapy Successfulness of Platina/Taxol Chemotherapy Protocol by Using Determination of Serum Urokinase Plasminogen Activator (uPA) and Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Patients With Ovarian Carcinoma FIGO II
Bosnian Journal of Basic Medical Sciences
Medicine
Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms
Gut
Gastroenterology
Increased Soluble Urokinase Plasminogen Activator Receptor (suPAR) Is Associated With Thrombosis and Inhibition of Plasmin Generation in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Experimental Hematology
Cancer Research
Genetics
Hematology
Molecular Biology
Cell Biology
Role of Urokinase Plasminogen Activator Receptor–Associated Protein in Mouse Lung
American Journal of Respiratory Cell and Molecular Biology
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Cell Biology
Molecular Biology
Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
Medicina
Medicine
Accessibility of Receptor-Bound Urokinase to Type-1 Plasminogen Activator Inhibitor.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Ligand Binding Regions in the Receptor for Urokinase-Type Plasminogen Activator
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans With CKD
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
